Introduction
Iridocyclitis is a common disease that often takes on a recurrent chracter and affects young working-age people. According to different authors, iridocyclitis is a cause of blindness in 5 -30% and 25% cases, which determines the importance and relevance of studying pathogenesis of the disease development [8] . Over the late decades, a great number of dangerous viruses have been discovered (Ebola Virus, AIDS, Marburg virus and etc.); viruses mutate actively, recombination in the virion genome takes place and viruses become resistant to traditional therapy. Human immune system does not always manage to prevent from virus replicating in the organism; immunodeficiency develops against the background of long-term persistent viral infection. The eye is under the fire of virus attacks in patients of different age in the presence of low immune function. Over the last decade, the ratio of virus infection as an etiologic agent in endogenous uveitis development has increased. Viral infections have gained a footnote and ground in human population, affecting all organs and systems of the host and developing acute, sub-acute, and chronic forms. Today, viral infection (VI) is considered as a systemic disease of the organism [1] . Expert committee of World Health Organization (WHO) has predicted an intensive VI incidence in the current century and WHO European Bureau published a report back in 1987, in which they pointed that "… herpesvirus infections will determine the future of the viral pathology in the XXI century". 300 000 to 500 000 people with various herpes forms seek for ophthalmic help annually, where 60 % of a total number are the patients with herpetic keratitis and iridocyclitis [6] .
The role of immune response has been defined in inflammation development in the uveal tract. It is known that neutrophils and macrophages migrate to the focus of inflammation in cell immunity activation (as delayed type hypersensitivity), in consequence of their activity, the reproduction of pathology causing agents is managed. The state of immune system in uveitis patients is defined considerably by immunocompetent cells' producing cytokines that participate in formation of systemic and immune responses in different eye diseases [4, 5, 7, 10] .
Recombinant interferon, the action mechanism of which consists in the possibility to induce the formation of high titre of endogenous interferons [9, 12] , has been shown prospective in the uveitis treatment [2, 13] ; the main producers of recombinant interferon are macrophages, T-and B-lymphocytes [14] . Taking into account these facts, it is reasonable to find out if there is a correlation between directivity and intensity of changes in cellular and humoral components of immunity when uveal tract inflammation develops and in respect of clinical signs of the disease and changes in cytokine component of immunity (due to interferon level in blood serum). Besides, immunological studies of the course of the disease will make it possible to correct pathogenic and etiotropic treatment assigned, considering the pronouncement degree of damage in every patient. Since natural killer (NK) cells are capable to control the virus spread in as little as few hours after infection, many viruses have developed the mechanisms to modulate the activity of NK cells, "hiding" from immune response activation. The necessity to use antiviral drug with immunomodulatory activity, that increases immunobiological resistance, is obvious.
Allokin-alpha is an antiviral drug, one of a new family of natural antiviral peptides, the one of Ukraine's immunostimulant that directly activates natural killers (NK) and acts directly in the affected area not inducing immune hyperresponsiveness. It belongs to pharmacological class "Antiviral and immunomodulatory drug. Interferon inducer".
Allokin-alpha is a synthetic linear cytokine-like oligopeptide with molecular weight of 1 265 Daltons and it consists of 13 L-amino-acids with alloferon as an active ingredient. Its action is focused on enhancement of virus antigen and infected cell recognition by natural killers, neutrophils and other natural immunity effectory systems that are responsible for virus elimination [11] and defected cell lysis by cytotoxic lymphocytes.
Purpose. To study changes in the clinical condition of the eye and the state of cellular and humoral immunity in iridocyclitis patients under the influence of allokinalpha anti-viral drug. Each patient was examined using a standard ophthalmic test protocol including visual acuity test, tonometry, ophthalmoscopy, visual field test, and tissue and humoral immunity studies.
Material and Methods
Peripheral blood was studied immunologically.
Parameters of T-cell immunity (T-lymphocyte population as well as subpopulations, T-helpers/inducers and T-suppressors/cytotoxic natural killers) were detected immunohistologically using CD 3+, CD 4+, CD 8+, CD 16+ monoclonal antibodies [11]. Properties of CD 16 (NK cells) to kill directly infected cells or to produce cytokines in the affected area contribute to getting virus spread under control and to virus prevalence limiting ability. Humoral immunity was assessed according to the level of b-lymphocytes (using CD 19+ donators of immunoglobulin (Ig) of various classes) and to the level of IgA, IgM, IgG using radial immunodiffusion assay (Mancini method).
The data obtained were statistically processed by Statistica 7.0 software using pairwise Student criterion and nonparametric χ 2 criterion with preliminary normality test.
Results and Discussion
Changes in parameters of cellular and humoral immunity in viral iridocyclitis patients over the course of allokin-alpha treatment are given in Table 1 . The inflammation onset was against the background of lymphopenia, which indicates secondary immunodeficiency and reduced immunoresistance of the organism. To assess the state of immune system, it is important to consider the state of CD-3 as a mirror reflecting pathologic processes in the diseased organism. In uveitis patients, we observed a significant decrease by 41%, р<0.05, (Table 1) in the amount of CD-3 lymphocytes in the peripheral blood, which was lower than that in control group patients. These changes evidence the apparent deficiency of a general T-lymphocyte pool in iridocyclitis patients. At 18 days after 6 allokin-alpha injections, a relative value of T-lymphocytes increased from (38.2±0.53)% up to (63.4±1.19)% (р<0.05).
СD-4 (T-helpers) are drown a special attention to in inflammatory process since these cells play an important role nearly in all immune cell and antibodymediated responses. Various CD-4 T-cells produce different cytokine sets for humoral immune response; they are known as well as TDTH cells (delayed-type hypersensitivity T cells), cytokines for cellular immunity. Besides, HIV enters T-cell through this receptor.
T-helper count before allokin-alpha treatment was decreased (by 33.3% (р<0.05) lower than age norm). It gradually increased over the course of treatment. At
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CD-8 is a surface molecule of the most cytotoxic Tlymphosites. T-suppressor count in all viral iridocyclitis patients was found to be higher as compared to control. This tendency was kept and T-suppressor count remained increased (by 54% higher than the norm (р<0.05)) at 18 days after treatment start.
The immunoregulatory index (IRI) (CD-4/CD-8 ratio) in the peripheral blood is diagnostically valuable and prognostic informative parameter for immune system assessment.
As it appears from the data in Table 1 , IRI increased significantly from 1.16 up to 2.00 (p=0,00008) over the course of treatment, nearing the normal range at the end of treatment (Table 1) .
Studying the changes in CD-19 lymphocytes, we found that CD-19 lymphocyte level steady decreased from 24.4% to 21.8 % at 18 days after treatment start.
Taking into account T-lymphocyte disorders in patients examined, the ratio of main immunoregulatory subpopulations of CD-4 and CD-8 lymphocytes is of interest. We determined significant changes in relative T-helper lymphocyte count in the peripheral blood as compared to control, which indicates autoimmune shifts in the peripheral blood of patients in comparison with control group of healthy patients. Against the background of apparent T-lymphocyte deficiency, we determined a decrease in CD-4 lymphocyte proportion in the peripheral blood of viral iridocyclitis patients as compared to control group values. Besides, CD 16 (NK) count increased significantly, that enhances body resistance to viral infection.
As for humoral immunity in uveitis patients, we detected an increase in relative B-lymphocyte count and IgA level as compared to norm. IgM level was increased and, after treatment, it decreased twice with its value settling down within the normal range. IgG level in iridocyclitis patients decreased twice over the course of treatment and substantially corresponded the norm (р<0.02).
The data obtained in assessment of cellular and humoral immunity in viral iridocyclitis patients are of practical importance with the point of choice of rational pathogenically-oriented treatment including anti-virus, desensitizing and immunecorrecting therapy. All patients were prescribed allokin-alpha as anti-virus therapy and immune system correction.
Outcomes of treatment performed showed the treatment success and positive changes in the clinical picture and visual acuity. To assess the efficacy of proposed treatment in uveitis patients, we used a number of criteria and, first of all, changes in VA. VA changes against the treatment in all groups of uveitis patients are given in Table 2 . 
